Journal Mobile Options
Table of Contents
Vol. 9, No. 4, 2002
Issue release date: July–August 2002
Section title: Original Paper
J Biomed Sci 2002;9:311–320
(DOI:10.1159/000065001)

Pharmacokinetics of Methyl Parathion: A Comparison following Single Intravenous, Oral or Dermal Administration

Kramer R.E. · Wellman S.E. · Rockhold R.W. · Baker R.C.
Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Miss., USA

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

For eJournal Archive and eJournal Backfiles information please contact service@karger.com


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: 7/19/2002
Issue release date: July–August 2002

Number of Print Pages: 10
Number of Figures: 4
Number of Tables: 2

ISSN: 1021-7770 (Print)
eISSN: 1423-0127 (Online)

For additional information: http://www.karger.com/JBS

Abstract

Assessment of the risks posed by the residential use of methyl parathion requires an understanding of its pharmacokinetics after different routes of exposure. Thus, studies were performed using adult female rats to define the pharmacokinetic parameters for methyl parathion after intravenous injection and to apply the described model to an examination of its pharmacokinetics after single oral or dermal exposure. The pharmacokinetics of methyl parathion after intravenous administration (1.5 mg/kg) were best described by a three-compartment model; the apparent volume of the central compartment was 1.45 liters/kg, clearance was 1.85 liters/h/kg and the terminal half-life was 6.6 h with an elimination constant of 0.50 h–1. The apparent oral absorption coefficient for methyl parathion (1.5 mg/kg) was 1.24 h–1, and its oral bioavailability was approximately 20%. The latter likely includes a significant first pass effect. Concentrations of methyl parathion increased during the initial 10–60 min and then declined during the next 15–36 h. After dermal administration (6.25–25 mg/kg), methyl parathion concentrations peaked within 12–26 h and then declined dose dependently. The apparent dermal absorption coefficient was approximately 0.41 h–1, and only two pharmacokinetic compartments could be distinguished. In conclusion, the pharmacokinetics of methyl parathion are complex and route dependent. Also, dermal exposure, because of sustained methyl parathion concentrations, may pose the greatest risk.

© 2002 National Science Council, ROC and S. Karger AG, Basel


  

Author Contacts

Robert E. Kramer, PhD, Department of Pharmacology and Toxicology
University of Mississippi Medical Center, 2500 North State Street
Jackson, MS 39216-4505 (USA)
Tel. +1 601 984 1604/601 984 1600, Fax +1 601 984 1637
E-Mail rkramer@pharmacology.umsmed.edu

  

Article Information

Received: Received: November 22, 2001
Accepted: February 19, 2002
Number of Print Pages : 10
Number of Figures : 4, Number of Tables : 2, Number of References : 45

  

Publication Details

Journal of Biomedical Science (Sponsored by the National Science Council, Taipei)

Vol. 9, No. 4, Year 2002 (Cover Date: July-August 2002)

Journal Editor: S.H.H.Chan, Kaohsiung
ISSN: 1021–7770 (print), 1423–0127 (Online)

For additional information: http://www.karger.com/journals/jbs


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: 7/19/2002
Issue release date: July–August 2002

Number of Print Pages: 10
Number of Figures: 4
Number of Tables: 2

ISSN: 1021-7770 (Print)
eISSN: 1423-0127 (Online)

For additional information: http://www.karger.com/JBS


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.